Introduction
Main te nance di al y sis treat ment saves annually the lives of over a quar ter of a million Amer i cans and mil lions of in di vid u als through out the world, who oth er wise would not have sur vived end-stage kid ney dis ease. The clin i cal out come of these in di vid u als, how ever, has re mained poor; in clud ing an annual mor tal ity rate of ap prox i mately 20% and a to tal hos pi tal iza tion of 10 -15 days per patient-year in the United States [USRDS 2003 ]. The di al y sis-associated mor tal ity, currently worse than many ma lig nant dis eases, has re mained high de spite ad vances in re nal re place ment ther apy in the past three de cades. Car dio vas cu lar dis ease is the ma jor cause of death in these pa tients, ac count ing for more than half of all deaths [USRDS 2003 ]. However, con ven tional car dio vas cu lar risk fac tors such as obe sity, hy per cho les ter ol emia, hy perten sion or hyperhomocystinemia do not appear to be strong pre dic tors of di al y sis mor tality; par a dox i cally, a low, rather than a high body mass in dex, blood pres sure and se rum lev els of cho les terol or plasma homocysteine are as so ci ated with a poor clin i cal out come in di al y sis pa tients, a phe nom e non that has thus been called "re verse ep i de mi ol ogy" [Kalantar-Zadeh et al. 2003a ]. On the other hand, such non tra di tional risk fac tors of car dio vas -cu lar dis ease as se rum al bu min and C-reactive pro tein are strong pre dic tors of mor tal ity in these in di vid u als [Yeun and Kaysen 1998, Zim mer mann et al. 1999 ].
In the con text of the on go ing search for more novel but con ve niently avail able markers of clin i cal out come in main te nance di al ysis pa tients, Reddan et al. [2003] re cently reported that white blood cell count (WBC) and such com po nents as lym pho cyte and neutrophil counts were strong mor tal ity pre dic tors in main te nance hemodialysis (MHD) out patients. They found that the mor tal ity pre dictabil ity of lym pho cyte count was weaker than the to tal WBC and its other com po nents. How ever, these and other in ves ti ga tors have stud ied the ab so lute counts of WBC and its frac tions and not the per cent ages that are usually mea sured a pri ori and in de pend ently of the ab so lute counts. More over, the neutrophil count (both in form of the ab so lute count and the per cent age frac tion) usu ally has a strong cor re la tion with WBC (r > 0.5) and, hence, may not re flect a dif fer ent marker than WBC it self, whereas the as so ci a tion be tween lympho cyte per cent age (LYM%) and WBC is usu ally low [Reddan et al. 2003 ]. More over, no study has ex am ined the re la tion ship between hos pi tal iza tion, an in di ca tor of mor bidity, and WBC com po nents. We have ex amined the hy poth e sis that the in de pend ently mea sured LYM% is a marker of malnutrition-inflammation com plex syn drome and a strong and in de pend ent pre dic tor of both mor tal ity and 3 dif fer ent mea sures of hos pital iza tion in di al y sis pa tients. We also explored whether the out come pre dict abil ity of LYM% is su pe rior to that of the ab so lute lympho cyte count and/or the to tal WBC.
Methods

Patients
The DaVita South Bay Co hort con sists of 10 out pa tient di al y sis fa cil i ties in the Los Angeles area, lo cated within a 15-mile ra dius from Har bor-UCLA Med i cal Cen ter, and admin is tered us ing uni form treat ment prac tices by DaVita, Inc. More over, a sin gle cen tralized lab o ra tory an a lyzes vir tu ally all rou tine lab o ra tory mea sure ments. This co hort has been fol lowed closely since Oc to ber 2001, es pe cially since it con sti tutes the base population for the "Nu tri tional and In flam ma tory Eval u a tion in Di al y sis" (NIED) Study (see NIED Study website at www.NIEDstudy.org for more de tails, as well as pre vi ous publications [Kalantar-Zadeh et al. 2003c , 2004a ). In clu sion cri te ria were treat ment with MHD and aged 18 years or older. Es sen tially, all MHD pa tients from 10 di al y sis fa cil i ties were in cluded in this co hort. The study was ap proved by the In sti tu tional Re view Commit tee of the Re search and Ed u ca tion In stitute at Har bor-UCLA Med i cal Cen ter and was ex empted from writ ten con sent re quirements.
The NIED Study co hort, which is es sentially a subcohort of DaVita South Bay Co hort, was also an a lyzed dur ing the same pe riod of time for com par i son with the main co hort. The med i cal chart of each MHD pa tient in this subcohort was thor oughly re viewed by a nephrologist (KKZ) and data per tain ing to under ly ing kid ney dis ease, car dio vascular history and other comorbid con di tions were extracted as de scribed else where [Kalantar-Zadeh et al. 2004a,b] . A mod i fied ver sion of the Charlson comorbidity in dex, i.e. with out the age and kid ney dis ease com po nents, was used to as sess the se ver ity of comorbidity [Beddhu et al. 2000 , Fried et al. 2001 ].
Malnutrition-inflammation score (MIS)
Us ing the seven com po nents of the conven tional SGA (Sub jec tive Global As sessment of Nu tri tion) [Kalantar-Zadeh et al. 1998 ], a semiquantitative scale with three sever ity lev els, and com bin ing it with three new el e ments (body mass in dex, se rum al bu min and to tal iron bind ing ca pac ity (TIBC) to repre sent se rum transferrin) in in cre men tal fashion, the so-called "malnutrition-inflamma tion score" (MIS) with 10 com po nents has been cre ated [Kalantar-Zadeh et al. 2001] . Each MIS com po nent has four lev els of se ver ity from 0 (nor mal) to 3 (very se vere). In two recent pro spec tive stud ies, the MIS has been found to be a com pre hen sive scor ing sys tem with sig nif i cant as so ci a tions with pro spec tive hos pi tal iza tion and mor tal ity as well as measures of nu tri tion, in flam ma tion and ane mia in MHD pa tients and is su pe rior to con ven -tional SGA and to in di vid ual lab o ra tory values as a pre dic tor of di al y sis out come and an in di ca tor of MICS [Kalantar-Zadeh et al. 2001 , 2004c .
Mortality
Pa tients were stud ied from Oc to ber 1, 2001 1, , through Sep tem ber 30, 2002 . Their mortal ity was de ter mined ir re spec tive of the cause of death dur ing the 12-month pro spec tive period. Sur vival was ver i fied by con firm ing the ex is tence of the sur viv ing pa tient in the da ta -base of the sub se quent quar ters af ter the end of the co hort study pe riod, i.e. af ter Sep tember 30, 2002. For all sur viv ing pa tients, the right cen sor ship co hort time was 12 months. For a sur viv ing pa tient with a right cen sor ship time less than 12 months, the cause of the removal from the study was de ter mined by review ing the 12-month lon gi tu di nal data and in cluded re nal trans plan ta tion, quit ting di al ysis treat ment and trans fer ring out of the di al ysis co hort area. For pa tients who changed the mo dal ity to peritoneal di al y sis and re mained in the co hort area, the fol low-up for mor tal ity was con tin ued based on the in ten tion-to-treat prin ci ple.
Hospitalization measures
Hos pi tal iza tion was de fined as any hos pital ad mis sion that in cluded at least one overnight stay in the hos pi tal. The ad mis sion day was counted as one full hos pi tal iza tion day, but the dis charge day was not. There fore, the min i mum du ra tion of hos pi tal iza tion per admis sion was one day. No ex clu sion cri te ria for de ter min ing hos pi tal iza tions were used ex cept for re nal trans plan ta tion. Since the vast ma jor ity of "di al y sis ac cess"-re lated hospi tal iza tions did not re quire over night ad mission, es sen tially only those di al y sis accessrelated hos pi tal iza tions were in cluded that were as so ci ated with other mor bid con di tions such as in fec tion or car dio vas cu lar events. For those pa tients in the hos pi tal at the start of this co hort study, that hos pi tal iza tion was not counted. If they stayed in the hos pi tal long enough to miss the co hort base line's lab o ratory tests, they were ex cluded. For pa tients who were still in the hos pi tal at the end of the 1-year co hort study, all hos pi tal iza tion days of the last ad mis sion were counted up to a max i mum of 30 days. For those pa tients who died and those who left the co hort prior to the com ple tion of the full 12-month fol low-up pe riod, the hos pi tal iza tion rates were stan dardized, since the de nom i na tor of the rate was patient-time. To mit i gate the ef fect of out liers, for any hos pi tal iza tion fre quency that was more than 12 times per year, the fre quency rate was in di cated as 12 times per year (n = 17), and any to tal hos pi tal iza tion days value that was more than 120 days per year was in di cated as 120 days (n = 13). Three meth ods were used to as sess the 12-month pro spec tive hos pi tal iza tion: the an nual hos pi tal iza tion fre quency (H F ) was the to tal num ber of hos pi tal ad missions dur ing the 12-month pro spec tive co hort ir re spec tive of the length of each ad mis sion, the an nual hos pi tal iza tion days (H D ) were the sum of all hos pi tal iza tion days of a given pa tient dur ing the same 12-month pe riod, the num ber of days at risk from the start of the co hort un til the first hos pi tal iza tion event for each in di vid ual per year was as -sessed in a sur vival model (H T ), ir re spec tive of ad di tional sub se quent hos pita li zations.
Ac cord ingly, the risk time for each in divid ual is de fined as the days from study en try un til the first hos pi tal iza tion, a cen sor ing event, or the study an ni ver sary day oc curs.
Laboratory evaluation
Rou tine blood sam ples were ob tained simul ta neously and in a uni form fash ion in all 10 di al y sis clin ics within the first full week of a given month, e.g. Oc to ber 1 through 6, 2001, for the first co hort month. LYM% was measured a pri ori and in de pend ently of the to tal WBC count via au to mated meth ods (he lium neon flow cytometry) [Terstappen et al. 1988 ]. Ab so lute lym pho cyte count was cal cu lated as the prod uct of WBC and LYM%:
LYM count = LYM% * WBC/100
The sin gle-pool Kt/V was used to rep resent the weekly di al y sis dose and the nor malized pro tein equiv a lent of to tal ni tro gen appear ance (nPNA), also known as nor mal ized pro tein cat a bolic rate (nPCR) was cal cu lated to es ti mate the daily pro tein in take [Bergstrom et al. 1991 , Daugirdas 1989 ]. Blood hemoglobin was mea sured weekly to bimonthly. Se rum ferritin and in tact parathyroid hor mone were mea sured at least once dur ing the first week of Oc to ber 2001. All other lab o ra tory val ues in clud ing WBC were mea sured monthly. All lab o ra tory mea surements were per formed in one sin gle lab o ra tory fa cil ity, i.e. DaVita Lab o ra tories (De land, FL, USA), us ing au to mated and stan dard ized meth ods. The base line WBC and LYM% values ob tained and mea sured dur ing the first week of the co hort were an a lyzed as pre dictors of out come. For sub jects who sur vived more than two or three months, up to two more months of val ues were also ob tained if avail able, and the 3-month av er aged val ues were stud ied. For all other lab o ra tory val ues and co-vari ates, ei ther the co hort base line val ues or av er aged val ues of up to first 13 weeks of the co hort (when ever avail able) were used in the mod els.
In sub jects of the NIED subcohort, the high-sensitivity C-reactive pro tein (CRP) was mea sured by a turbidometric immuno - assay in which a se rum sam ple is mixed with la tex beads coated with anti-human CRP an tibod ies form ing an in sol u ble ag gre gate (manu fac turer: WPCI, Osaka, Ja pan, unit: mg/l, nor mal range: < 3.0 mg/l) [Erbagci et al. 2002 , Ridker et al. 2002 . High-sensitivity interleukin-6 (IL-6) and tu mor ne cro sis fac tor-α (TNF-α) immunoassay kits based on a solid phase sand wich ELISA us ing re com bi nant hu man IL-6 and TNF-α were used to mea sure se rum pro-inflammatory cytokines (man ufac turer: R&D Sys tems, Min ne ap o lis, MN, USA, units: pg/ml, nor mal range: IL-6: < 9.9 pg/ml, TNF-α: < 4.7 pg/ml) [Kalantar-Zadeh et al. 2003c ]. CRP and cytokines were measured in the GCRC Core Lab o ra tories of Harbor UCLA Med i cal Cen ter. Se rum prealbumin con cen tra tions were mea sured via au to mated meth ods in the Har bor-UCLA Clin i cal Lab o ra tory. Lab o ra tory data were ex tracted and av er aged via KLINLAB software [Kalantar-Zadeh et al. 2003c ].
Statistical and epidemiological methods
Con ven tional Stu dent's t-test and anal y sis of vari ance (ANOVA) were used to de tect sig nif i cant dif fer ences among con tin u ous vari ables in two or more groups, re spec tively, when ap pli ca ble. Chi-square and Kruskal-Wallis rank tests were used for cat e gor i cal vari ables. We used Pearson's cor re la tion coef fi cient r for anal y ses of as so ci a tions between con tin u ous vari ables and Spearman's rank test for cat e gor i cal vari ables. Par tial corre la tion ad justed for case-mix co-vari ates was cal cu lated us ing lin ear multivariate models. To cal cu late the rel a tive risk of first hos pi - tal iza tion (H D ) and death in the pro spec tive co hort, haz ard ra tios (HR) and their 95% confidence in ter vals were ob tained us ing Coxproportional haz ard re gres sion mod els. The co-vari ates in cluded age, sex, race (Blacks vs. oth ers and Asians vs. oth ers), eth nic ity (Hispan ics vs. oth ers), dia betes, di al y sis vin tage (in month), in sur ance sta tus (Medicaid vs. oth ers), body mass in dex, Kt/V (sin gle pool), se rum al bu min and ferritin con cen tra tions, and blood he mo glo bin. Plots of log (-log (sur vival rate)) against log (sur vival time) were per formed to es tab lish the va lid ity of the pro por tion al ity as sump tion for Cox mod els. The Pois son re gres sion mod els with same co-vari ates were used to eval u ate the as so ci ation be tween hos pi tal iza tion data (H D and H F ) and rel e vant pre dic tors by cal cu lat ing the hos pi tal iza tion rate ra tio (RR). Any 95% confi dence in ter val (CI) not in clud ing 1.00 was con sid ered sta tis ti cally sig nif i cant. De scriptive and multi variate sta tis tics were car ried out with the sta tistical soft ware Stata, ver sion 7.0 (Stata Cor por ation, Col lege Sta tion, Texas, USA). Fiducial lim its are given as means ± SD (stan dard de vi a tion). A p value of < 0.05 is con sid ered to be sta tis ti cally sig nif i cant.
Results
De mo graphic, lab o ra tory and clin i cal data of the MHD pa tients at base line of both the main co hort and the subcohort are summa rized in Ta ble 1. The main co hort con sisted of 1,283 MHD pa tients at base line who were fol lowed for a to tal of 1,077 pa tient-years. The subcohort in cluded 372 MHD pa tients at base line and 322 pa tient-years through out the co hort time. Dur ing the 12-month follow up, 179 (14%) pa tients died and 732 (57%) patients were hos pi tal ized at least once. The annual hos pi tal iza tion fre quency was 1.9 times per pa tient per year, and the to tal days of hospitalization were on av er age 11.5 days per pa tient-year. In the subcohort, 50.1% of all pa tients had a his tory of car dio vas cu lar disease. Ta ble 1 also shows mean ± SD val ues of in flam ma tory mark ers in the subcohort.
Ta ble 2 shows both un ad justed and multivariate ad justed cor re la tion co ef fi cients between the WBC and LYM% and rel e vant clin ical and lab o ra tory vari ables. The WBC had an in verse cor re la tion with LYM% (r = -0.36). Older pa tients had higher WBC and lower LYM% val ues. Blood he mo glo bin and se rum Ta ble 2. Cor re la tions among rel e vant val ues in the main co hort (n = 1,283) and the subcohort* (n = 372). Multivariate ad justed par tial cor re la tions are con trolled for age, gen der, race (Blacks vs. oth ers and Asians vs. oth ers), eth nic ity (His panic vs. oth ers), di a be tes mellitus, in sur ance sta tus (Medicaid vs. oth ers), di al y sis vin tage, body mass in dex, Kt/V (sin gle-pool), nPNA, blood he mo glo bin, and serum lev els of al bu min and ferritin. (r val ues > 0.10 are in bold); § = log a rithm of in flam ma tory mark ers (CRP, IL-6 and TNF-α) were modeled. .08 (p = 0.003) +0.20 (p < 0.001) -0.02 (p = 0.5) -0.14 (p < 0.001) Body mass in dex +0.10 (p = 0.001) +0.02 (p = 0.6) +0.09 (p = 0.002) +0.01 (p = 0.6) Di al y sis vin tage -0.09 (p = 0.003) +0.02 (p = 0.5) -0.04 (p = 0.13) -0.04 (p = 0.19) Kt/V (sin gle-pool) -0.04 (p = 0.20) +0.09 (p = 0.004) -0.06 (p = 0.05) +0.12 (p < 0.001) nPNA +0.03 (p = 0.22) -0.01 (p = 0.6) +0.08 (p = 0.004) -0.08 (p = 0.005) Blood he mo glo bin -0.06 (p = 0.023) +0.15 (p < 0.001) -0.03 (p = 0.4) +0.13 (p < 0.001) Se rum al bu min -0.14 (p < 0.001) +0.18 (p < 0.001) -0.12 (p < 0.001) +0.11 (p < 0.001) Creatinine -0.12 (p < 0.001) +0.20 (p < 0.001) -0.04 (p = 0.17) +0.12 (p < 0.001) TIBC -0.04 (p = 0.17) +0.13 (p < 0.001) -0.01 (p = 0.9) +0.07 (p = 0.01) Ferritin +0.11 (p < 0.001) -0.11 (p < 0.001) +0.12 (p < 0.001) -0.08 (p = 0.004) CRP*, § +0.11 (p = 0.05) -0.11 (p = 0.02) +0.07 (p = 0.18) -0.07 (p = 0.19) Interleukin-6*, § +0.16 (p = 0.002) -0.19 (p = 0.003) +0.17 (p = 0.002) -0.14 (p = 0.01) TNF-α*, § +0.02 (p = 0.7) +0.04 (p = 0.5) +0.03 (p = 0.6) +0.04 (p = 0.05) Prealbumin* +0.02 (p = 0.7) +0.12 (p = 0.03) +0.06 (p = 0.21) +0.01 (p = 0.9) MIS * +0.06 (p = 0.3) -0.25 (p < 0.001) +0.05 (p = 0.3) -0.22 (p < 0.001) Charlson in dex* +0.16 (p = 0.002) -0.24 (p < 0.001) +0.05 (p = 0.3) +0.01 (p = 0.9) con cen tra tions of al bu min, creatinine and to tal iron bind ing ca pac ity (TIBC) had weak and neg a tive as so ci a tions with WBC and pos i tive as so ci a tions with LYM%. In the sub cohort, both the un ad justed and multivariate ad justed cor re la tions be tween blood cell counts and serum IL-6 were sig nif i cant. The most prom inent as so ci a tion, how ever, was the neg a tive cor re la tion be tween the LYM% and the MIS (r = -0.25), which re mained sig nif i cant and strong even af ter com pre hen sive multivariate ad just ment (r = -0.22). On the con trary, the WBC did not cor re late with the MIS. Ta ble 3 ex hib its the quan ti ta tive value of each out come mea sure within the quartiles of WBC and LYM%. In the main co hort, mor tality was es sen tially dou bled in the high est (4th) quartile of WBC (≥ 8,500), i.e. 22.9% vs. 10.0 -11.7% in the other three quartiles. A sim i lar dis tri bu tion trend was no ticed with hos pi tal iza tion mea sures. The low est (first) LYM% quartile (≤ 15.5%) had the high est mor tal ity of 22.9%. Un like WBC quartiles, a pro gres sively dec re ment ing trend of mor tality across the other 3 LYM% quartiles in both the main and the subcohort was ob served. A sim i lar down ward trend was also found for hos pi tal iza tion mea sures. Sim i lar anal y ses were con ducted for the ab so lute lym pho cyte count, i.e. the math e mat i cal prod uct of WBC and LYM%. While the low est lym pho cyte quartile ex hib ited the high est mor tal ity, the high est lym pho cyte quartile also had somewhat in creased mor tal ity com pared to the two mid dle quartiles (U-shaped trend). Figure 1 de picts the dis tri bu tion his to grams for WBC and LYM%, the "high risk" quartile in each histogram is marked by as ter isks (*). Ta ble 4 shows the rel a tive risk of mor tality and hos pi tal iza tion in four quartiles of WBC. Both the con tin u ous value of WBC and its quartiles (across four quartiles, high est vs. the rest, and high est vs. low est) were exam ined. The high est quar tile of WBC (≥ 8,500), as com pared to the low est quar tile and af ter ad just ment for co-vari ates, was as so ciated with 79% in crease in mor tal ity and 42% in crease in to tal hos pi tal iza tion days. Ta ble 5 in di cates the same sum mary es ti mates but for LYM%. The low est quar tile of LYM% (≤ 15.5%), as com pared to the high est, was as soci ated with a 111% in crease in mor tal ity and 68% in crease in to tal hos pi tal iza tion days.
The 12-month cu mu la tive pro por tion of sur viv ing pa tients in four quartiles for WBC and LYM% are shown in Fig ure 2 . The Kaplan -Meier p value was < 0.0001 for both WBC and LYM%. While sur viv als in three low est WBC quartiles were some what sim i lar to each other as com pared to the high est quartile, the sur vival in LYM% quartiles had an in cre men tal trend across the in creas ing quar ti les, which is con sis tent with the find ings in Ta ble 2. Fig ure 3 shows the rel a tive risk of death for each LYM% quartile as com pared to the high est quartile of LYM% (≥ 25.5%). This Fig ure in di cates the decre mental trend of the haz ard ra tio of death across four LYM% quartiles. Sim i lar trends were also found for 3 mea sures of hos pi tal iza tion (data not shown here). Fi nally, when both LYM% and WBC quartiles were added si mul ta neously to the same multivariate Cox model for mor tal ity, the WBC quartile term lost its sta tis ti cal sig nif icance (p = 0.087), while LYM% quartile was still sig nif i cantly as so ci ated with mor tal ity Lym pho cyte per cent age, mal nu tri tion-in flam ma tion and di al y sis out come 29 Ta ble 4. Rel a tive risk of poor out come based on in creased WBC: A. Rel a tive risk of death for white blood cell count (WBC) based on mor tal ity haz ard ra tio (HR), B. Rel a tive risk of first hos pi tal iza tion for white blood cell count (WBC) based on Cox HR, C. Rel a tive ra tio (RR) of hos pi tal iza tion days for white blood cell count (WBC) based on Pois son model and D. RR of hos pi tal iza tion fre quency for white blood cell count (WBC) based on Pois son model. Multivariate mod els in cluded age, gen der, race (Blacks vs. oth ers, and Asians vs. others), eth nic ity (His panic vs. oth ers), di a be tes mellitus, in sur ance sta tus (Medicaid vs. oth ers), di al y sis vin tage, body mass in dex, Kt/V (sin gle-pool), nPNA, blood he mo glo bin and se rum levels of al bu min and ferritin. across de creas ing quartiles, with a haz ard ra tio of 1.30 (95% confidence in ter val: 1.108 -1.52, p = 0.001). Sim i lar find ings were noted for hos pi tal iza tion mea sures (data not shown here). Ab so lute lym pho cyte count had weaker as so ci a tions with out come and in the com bined model, which also in cluded the WBC, did not show any sig nif i cant as so ci ation with out come mea sures (data not shown here).
Discussion
The pres ent study showed that the percent age of lym pho cyte count (LYM%), and not ab so lute lym pho cyte count, had sig nif icant out come pre dict abil ity. Higher WBC and lower LYM% were in de pend ent pre dic -tors of both hos pi tal iza tion and death in MHD pa tients. They re mained so even af ter ad justing for 13 rel e vant case-mix vari ables, includ ing some strong mark ers of poor out come such as se rum al bu min. More over, the as so cia tion be tween the de creas ing LYM% quartiles and the clin i cal out come showed an incre men tal trend, but this was not the case with WBC, in which only the high est quartile, and no other quartiles, was as so ci ated with higher risk of mor tal ity. A model that si mul ta neously in cluded both WBC and LYM% quartiles indi cated that a de creas ing LYM% quartile was still as so ci ated with a poor out come. Moreover, the LYM% had sta tis ti cally sig nif i cant and in verse as so ci a tions with the "mal nu trition-in flam ma tion score" and se rum IL-6 level. The per cent age of the pe riph eral lym phocyte, like the per cent age val ues of other periph eral leu ko cyte frac tions, is usu ally measured di rectly via he lium neon flow cell method and in de pend ently of the to tal WBC count mea sure ments [Terstappen et al. 1988 ]. Ac cord ingly, many lab o ra tory re ports in dicate right fully only the LYM% and other differ en tial per cent ages but not the ab so lute lym pho cyte count. How ever, most pre vi ous stud ies [Ommen et al. 1997 , Pifer et al. 2002 , Reddan et al. 2002 , Thomson et al. 1995 ] eval u ated the ab so lute lym pho cyte count, which is usu ally a math e mat i cal product of two in de pend ently mea sured val ues, i.e. WBC times LYM%. While this re search prac tice of ex am in ing ab so lute counts, rather than in de pend ently mea sured per cent ages, is quite le git i mate, es pe cially for study ing the ab so lute neutrophil count, it ig nores the fact that the math e mat i cal prod ucts of two in depend ently mea sured lab o ra tory val ues, i.e. WBC and LYM%, each be ing in de pend ent out come pre dictors with op po site out come pre dict abil ity di rec tion, may lead to a strong math e mat i cal colinearity; hence, the re sul tant math e mat i cal prod uct may be a flawed marker. The same ar gu ment has been on go ing for the Kt/V, which is a math e mat i cal prod uct of two in de pend ent out come pre dic tors (Kt and V) [Lowrie et al. 1999] . Con sis tent with this hy poth e sis, we found that the ab so lute lym pho cyte count did not have the same linear ity and strong as so ci a tion with mor tal ity as the LYM% did. Sim i larly, Reddan et al. [2003] also re ported a weak as so ci a tion be tween abso lute lym pho cyte count and mor tal ity, but they did not ex am ine the LYM% in their anal yses. More im por tantly, phy si cians usu ally look at the dif fer en tial per cent ages and rarely perform a math e mat i cal cal cu la tion to ob tain the ab so lute counts in their rou tine pa tient manage ment, in clud ing med i cal care of di al y sis pa tients.
A higher WBC may in di cate the ex is tence of in flam ma tion or in fec tion, and this may be the cause of the as so ci a tion be tween WBC and poor out come [Ernst et al. 1987 , Furman et al. 1996 , Weijenberg et al. 1996 ]. In the gen eral pop u la tion, an in creased WBC has been found to cor re late with in creased car diovas cu lar mor tal ity in el derly men [Weijenberg et al. 1996 ] and with in creased mor tal ity fol low ing myo car dial in farc tion in gen eral [Furman et al. 1996 ]. In creased WBC has also been im pli cated as a biomarker for ath eroscle ro sis [Fuster and Lewis 1994] . More over, a re duced lym pho cyte count has been as so ciated with in creased mor tal ity in pa tients with con ges tive heart fail ure [Ommen et al. 1997 [Ommen et al. , 1998 ], and has also been iden ti fied as a bad prog nos tic sign in pa tients with cor o nary artery dis ease [Thomson et al. 1995 ]. An as soci a tion be tween WBC and mor tal ity in mainte nance di al y sis pa tients has also been sug gested in the past [Fried man 1994 , Lowrie 2002 , Reddan et al. 2003 ]. Reddan et al. [2003] showed in 25,661 MHD pa tients from Fresenius Med i cal Care of North Amer ica that a higher ab so lute lym pho cyte count was as so ci ated with higher se rum al bu min and creatinine, lower age and black race. In their study, Cox-proportional haz ard re gres sion showed that an in creased lym pho cyte count was as so ci ated with re duced mor tal ity risk (HR 0.86 (0.83 -0.89) per each 500/ml increase in lym pho cyte count). They con cluded that a re duced lym pho cyte count was as so ciated less strongly than the neutrophil count with sur ro gates of mal nu tri tion and in flamma tion, and that in creased neutrophil count and re duced lym pho cyte count were in de - In sum mary, we showed that a higher WBC and a lower per cent age of lym phocytes, two in de pend ently mea sured pe ripheral blood count com po nents, are as so ci ated with sig nif i cantly higher rates of mor tal ity and hos pi tal iza tion in MHD pa tients, even after ad just ing for blood he mo glo bin, in di cators of nu tri tion and in flam ma tion, di al y sis dose and de mo graphic fea tures. LYM% appears to be a more sen si tive mor tal ity and hospi tal iza tion pre dic tor, since even mild decreases in LYM% are as so ci ated with higher mor tal ity and morbidity rates. More over, LYM% had sig nif i cant and in verse as so ci ations with se rum IL-6 and the "malnutritioninflammation score". We sug gest that pe ripheral blood count, es pe cially LYM%, also should be used as fac tors when MHD pa tients are risk-stratified for clin i cal out come.
